Equinix (EQIX) Suffers a Larger Drop Than the General Market: Key Insights
https://www.zacks.com/stock/news/2331800/equinix-eqix-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2331800
Sep 04, 2024 - In the closing of the recent trading day, Equinix (EQIX) stood at $827.59, denoting a -0.55% change from the preceding trading day.
0
Sprinklr (CXM) Reports Q2 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2331776/sprinklr-cxm-reports-q2-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2331776
Sep 04, 2024 - Although the revenue and EPS for Sprinklr (CXM) give a sense of how its business performed in the quarter ended July 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Compared to Estimates, Couchbase (BASE) Q2 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2331778/compared-to-estimates-couchbase-base-q2-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2331778
Sep 04, 2024 - The headline numbers for Couchbase (BASE) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Verint (VRNT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2331777/verint-vrnt-q2-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2331777
Sep 04, 2024 - The headline numbers for Verint (VRNT) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2331780/phreesia-phr-q2-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2331780
Sep 04, 2024 - The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Compared to Estimates, AeroVironment (AVAV) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2331779/compared-to-estimates-aerovironment-avav-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2331779
Sep 04, 2024 - While the top- and bottom-line numbers for AeroVironment (AVAV) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
BlackBerry (BB) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2331738/blackberry-bb-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2331738
Sep 04, 2024 - BlackBerry (BB) closed the most recent trading day at $2.28, moving +0.88% from the previous trading session.
0
Meta Platforms (META) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2331714/meta-platforms-meta-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2331714
Sep 04, 2024 - Meta Platforms (META) closed at $512.74 in the latest trading session, marking a +0.19% move from the prior day.
0
Boeing (BA) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2331718/boeing-ba-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2331718
Sep 04, 2024 - Boeing (BA) concluded the recent trading session at $163.22, signifying a +1.37% move from its prior day's close.
0
J&J talc powder settlement backed by key attorney: report
https://seekingalpha.com/news/4147074-jj-talc-powder-settlement-backed-by-key-attorney-report?source=feed_sector_healthcare
Sep 04, 2024 - An attorney jointly representing around 12,000 claimants in litigation against J&J (JNJ) over its talc products reportedly supports the drugmaker’s latest settlement offer.
0